5 hours ago
6
A new clinical trial suggests that giving immunotherapy before surgery may dramatically improve outcomes for certain colorectal cancer patients. In the NEOPRISM-CRC study, patients treated with a short course of immunotherapy instead of chemotherapy after surgery have remained cancer-free for nearly three years.
The trial, led by researchers at UCL and UCLH, found that just nine weeks of treatment with pembrolizumab before surgery led to strong and lasting res...
English (US) ·